2022
DOI: 10.1080/03602532.2022.2144879
|View full text |Cite
|
Sign up to set email alerts
|

Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 85 publications
0
4
0
Order By: Relevance
“…The liver is a vital organ involved in various metabolic processes, drug metabolism, and detoxification [ 89 , 90 ]. Therefore, liver-specific nanozymes hold great potential for applications in liver-targeted drug delivery, liver disease diagnosis, and therapeutic interventions.…”
Section: Rational Design Strategiesmentioning
confidence: 99%
“…The liver is a vital organ involved in various metabolic processes, drug metabolism, and detoxification [ 89 , 90 ]. Therefore, liver-specific nanozymes hold great potential for applications in liver-targeted drug delivery, liver disease diagnosis, and therapeutic interventions.…”
Section: Rational Design Strategiesmentioning
confidence: 99%
“…Although the majority of the attention in drug metabolism studies has been paid to CYP, the other Phase I metabolism enzymes are being increasingly studied in recent years, including aldehyde oxidases (AOXs). AOXs are cytosolic non-NADPH dependent soluble molybdoflavo-enzymes belonging to the xanthine oxidase family [46]. They oxidize aldehydes to their corresponding carboxylic acids and hydroxylate N-heterocyclic compounds.…”
Section: Drug Metabolism Studiesmentioning
confidence: 99%
“…Among these, the transformation of N -heterocycles to the corresponding oxo- N -heterocycles is the most concerning AOX-mediated metabolic reaction in drug discovery. It has contributed to the clinical failure of many novel agents, such as carbazeran, BIBX1382, FK3453, JNJ-38877605, and Lu AF09535 11 , 12 , 13 . These drugs are mainly kinase inhibitors, as their structures generally include nitrogen-containing heterocycles as important binding motifs, making them more likely to be liable to AOX-mediated metabolism 14 , 15 , 16 .…”
Section: Introductionmentioning
confidence: 99%